LOXEN LP 50 mg, extended-release capsule 180 capsules
Active ingredients: Nicardipine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule180 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOXEN LP 50 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium polyamide aluminium de 180 gélule(s)
- Marketing authorisation holder
- LABORATOIRE XO
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Jul 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69198890CIP73719648CIP133400937196482Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NICARDIPINE (CHLORHYDRATE DE)gélule | 50 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.